| Literature DB >> 30320130 |
Christopher A O'Dea1,2,3, Karla Logie3,4,5, Andrew Maiorana2,6, Andrew C Wilson1,2,3,4, J Jane Pillow7,8, Georgia L Banton3, Shannon J Simpson2,3,4,9, Graham L Hall2,3,4,9.
Abstract
Evidence regarding the prevalence of expiratory flow limitation (EFL) during exercise and the ventilatory response to exercise in children born preterm is limited. This study aimed to determine the prevalence of EFL as well as contributing factors to EFL and the ventilatory response to exercise in preterm children with and without bronchopulmonary dysplasia (BPD). Preterm children (≤32 weeks gestational age) aged 9-12 years with (n=64) and without (n=42) BPD and term controls (n=43), performed an incremental treadmill exercise test with exercise tidal flow-volume loops. More preterm children with BPD (53%) had EFL compared with preterm children without BPD (26%) or term controls (28%) (p<0.05). The presence of EFL was independently associated with decreased forced expiratory volume in 1 s/forced vital capacity z-score and lower gestational age (p<0.05). There was no difference in peak oxygen uptake between preterm children with BPD and term controls (48.0 versus 48.4 mL·kg-1·min-1; p=0.063); however, children with BPD had a lower tidal volume at peak exercise (mean difference -27 mL·kg-1, 95% CI -49- -5; p<0.05). Children born preterm without BPD had ventilatory responses to exercise similar to term controls. Expiratory flow limitation is more prevalent in children born preterm with BPD and is associated with airway obstruction and a lower gestational age.Entities:
Year: 2018 PMID: 30320130 PMCID: PMC6174284 DOI: 10.1183/23120541.00048-2018
Source DB: PubMed Journal: ERJ Open Res ISSN: 2312-0541
FIGURE 1Demonstration of the assessment of expiratory flow limitation (EFL). a) A subject with no EFL; b) a subject with EFL >5%.
FIGURE 2Flow diagram of enrolment for the study. BPD: bronchopulmonary dysplasia; non-BPD: preterm children without BPD.
Neonatal and demographic details of the study population
| 64 | 42 | 43 | |
| 42 (66%)#,¶ | 32 (76%)# | 18 (42%) | |
| 26.0 (25–27.5)¶ | 30 (29.1–31.0) | ||
| 843 (709–993)¶ | 1420 (1238–1615) | ||
| −0.15±0.82 | −0.12±0.82 | ||
| 15.3 (4.4–32.8)¶ | 0.0 (0.0–1.0) | ||
| 14.5 (6.6–24.0)¶ | 0.7 (0.0–3.6) | ||
| 86.5 (57.5–98.0)¶ | 1 (0.0–3.0) | ||
| 29 (46%) | 15 (38%) | ||
| 23 (36%)¶ | 17 (44%) | ||
| 4 (6%)¶ | 10 (26%) | ||
| 10.8±0.6 | 10.9±0.6 | 10.6±0.6 | |
| 141 (136–146)¶ | 142 (138–148) | 145.5 (138–153) | |
| 32.4 (28.5–37.6)¶ | 36.5 (30.5–41.3) | 34.7 (30.0–42.2) |
Data are presented as mean±sd, median (interquartile range) or n (%), unless otherwise stated. Note the term controls did not have any neonatal intervention or respiratory symptoms. Not all children completed every question in the symptom questionnaire. BPD: bronchopulmonary dysplasia; non-BPD: preterm children without BPD; PMA: postmenstrual age; CPAP: continuous positive airway pressure. #: p<0.05 compared with healthy term controls; ¶: p<0.05 compared with non-BPD; +: exercise symptoms included parentally reported wheeze, cough and shortness of breath during exertion.
Lung function and exercise variables for children who completed a successful maximal exercise test
| 64 | 42 | 43 | |
| −0.83 (−1.57– −0.17)#,¶ | 0.09 (−0.91–0.37) | 0.04 (−0.57–0.61) | |
| −0.09 (−0.65–0.87)# | 0.37 (−0.25–0.97) | 0.24 (−0.65–0.86) | |
| −1.35 (−2.59– −0.80)# | −0.87 (−1.52– −0.41)# | −0.42 (−1.06–0.48) | |
| −0.28 (−0.92–0.53) | 0.25 (−0.50–0.78) | −0.12 (−1.06–0.48) | |
| 0.29 (−0.64–0.87) | 0.71 (−0.19–1.91)# | −0.07 (−0.68–0.36) | |
| −0.21 (−1.05–0.30) | 0.01 (−0.85–0.77) | −0.33 (−1.16–0.71) | |
| 1.53 (1.40–1.76)#,¶ | 1.78 (1.49–1.95) | 1.69 (1.45–2.17) | |
| 47.7 (42.8–53.2) | 46.1 (42.5–51.7) | 48.1 (45.5–52.4) | |
| 26.6 (13.9–47.2) | 31.0 (15.8–38.8) | 34.7 (13.6–45.3) | |
| 1.01 (0.98–1.02)# | 1.03 (1.01–1.06) | 1.04 (1.02–1.06) | |
| 196 (187–205) | 195 (185–202) | 200 (195–206) | |
| 24 (21–27) | 27 (23–30) | 28 (24–31) | |
| 64 (54–72)¶ | 54 (49–63) | 58 (54–68) | |
| 1.53 (1.36–1.72) | 1.40 (1.30–1.68) | 1.55 (1.42–1.81) | |
| 34.0 (28.2–35.8) | 37.2 (27.0–38.3) | 34.4 (30.0–37.1) | |
| 34 (53%)#,¶ | 11 (26%) | 12 (28%) | |
| 27.5 (0.0–60.0)#,¶ | 0.0 (0.0–26.5) | 0.0 (0.0–25.0) | |
| 25 (−83–193) | 110 (−78–225) | 25 (−90–203) | |
| −30 (−145–200) | −50 (−180–170) | −15 (−175–137) | |
| 397 (146–557) | 371 (238–648) | 368 (157–723) | |
| 32.0 (27.5–37.4) | 32.1 (28.0–35.1) | 30.1 (25.8–34.9) | |
| 31.8 (28.4–35.9) | 31.9 (27.6–36.6) | 29.9 (27.0–33.7) |
Data are presented as median (interquartile range), unless otherwise stated. BPD: bronchopulmonary dysplasia; non-BPD: preterm children without BPD; FEV1: forced expiratory volume in 1 s; FVC: forced vital capacity; TLC: total lung capacity; FRC: functional residual capacity; RV: residual volume; V′O: oxygen uptake; AT: anaerobic threshold; RQ: respiratory quotient; VT: tidal volume; fR: respiratory frequency; V′E: minute ventilation; EFL%VT: percentage of tidal volume assessed as meeting or exceeding the maximum flow–volume loop; IC: inspiratory capacity; EELV: end expiratory lung volume; EILV: end inspiratory lung volume. #: p<0.05 compared with healthy term controls; ¶: p<0.05 compared with non-BPD.
FIGURE 3Prevalence of expiratory flow limitation (EFL). BPD: bronchopulmonary dysplasia; non-BPD: preterm children without BPD. *: p<0.05.
Differences between preterm participants with and without expiratory flow limitation (EFL)
| 45 | 61 | |
| 34 (76%)* | 30 (49%) | |
| 28 (62%) | 43 (70%) | |
| 27.0 (25.0–29.2) | 28.6 (25.3–30.2) | |
| 5.0 (1.3–30.1) | 2.0 (0.0–13.5) | |
| 6.5 (1.0–24.9) | 5.6 (0.6–15.7) | |
| 74.0 (28.0–94.5)* | 22.0 (1.0–83.5) | |
| −1.31±0.96* | −0.12±0.83 | |
| −0.40 (−0.57–0.78) | 0.22 (−0.51–1.13) | |
| −1.85±0.89* | −0.71±0.83 | |
| 1.54 (1.40–1.78) | 1.63 (1.42–1.86) | |
| 49.6 (43.2–52.3) | 47.5 (42.4–52.3) | |
| 1.03 (1.01–1.05) | 1.01 (0.99–1.02) | |
| 197 (187–207) | 195 (186–202) | |
| 25 (22–28) | 25 (22–28) | |
| 62 (53–70) | 60 (52–69) | |
| 1.55 (1.36–1.74) | 1.43 (1.30–1.67) | |
| 31.1 (26.4–35.6) | 35.5 (29.3–38.5) | |
| 21 (48%) | 23 (40%) | |
| 23 (52%)* | 17 (29%) | |
| 4 (9%) | 10 (17%)* |
Data are presented as mean±sd, median (interquartile range) or n (%), unless otherwise stated. Not all children completed every question in the symptom questionnaire. BPD: bronchopulmonary dysplasia; PMA: postmenstrual age; CPAP: continuous positive airway pressure; FEV1: forced expiratory volume in 1 s; FVC: forced vital capacity; V′O: oxygen uptake; RQ: respiratory quotient; VT: tidal volume; fR: respiratory frequency; V′E: minute ventilation. *: p<0.05.
Binary logistic regression for neonatal and spirometry variables, for presence of expiratory flow limitation
| 0.184 (0.084–0.401)* | <0.001 | 0.477 | |
| 0.799 (0.640–0.997)* | 0.047 | ||
| 1.22 (0.674–2.200) | 0.514 |
FEV1: forced expiratory volume in 1 s; FVC: forced vital capacity; PMA: postmenstrual age. *: p<0.05.